E2F3 amplification primes bladder cancer cells for premature mitosis.
Kathryn A. Wierenga, Isabel S Nieland, Qingwu Liu, Pepijn R. J. Rakers, Anita van den Heuvel, Mara Pateli, Richard Wubbolts, Frank M. Riemers, Saskia C. van Essen, Elsbeth A. van Liere, Bart Westendorp
This study shows E2F3 amplification in bladder cancer cells leads to premature mitosis, which can be targeted by G2/M checkpoint inhibitors.
Cancer Gene Therapy · Sep 22, 2026Peer-reviewedCancer Biology